This brand name is authorized in Austria, Estonia, Finland, France, Lithuania, Poland, Romania.
The drug ENCEPUR contains one active pharmaceutical ingredient (API):
1
|
UNII
42XD79UQQ6 - TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
Encephalitis, tick borne suspension for injection is indicated for the active (prophylactic) immunization of persons of 16 years of age and older against tick-borne encephalitis (TBE). Its pharmacodynamic effect consists of the induction of a sufficiently high concentration of anti-TBE antibody to provide protection against the TBE virus. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07BA01 | Encephalitis, tick borne, inactivated, whole virus | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BA Encephalitis vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1012947, 1037461, 1064797, 1064876, 1078219 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 122638, 170636, 424470, 436303, 436311 |
| FR | Base de données publique des médicaments | 69431992 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1008311, 1011898, 1065124, 1065125, 1068121, 1068122 |
| PL | Rejestru Produktów Leczniczych | 100110435, 100192670 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W67660001, W67660002, W67660003, W67660004, W67661001, W67661002, W67661003, W67661004 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.